Korea, Republic of

Who we are

  • July 26, 2022
    A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer
  • May 23, 2022
    Sotorasib and Panitumumab Versus Investigator’s Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation (CodeBreak 300)
  • April 5, 2022
    A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas
  • April 5, 2022
    A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers
  • April 5, 2022
    A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors
  • April 5, 2022
    A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
  • April 5, 2022
    Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
  • April 5, 2022
    Curative Proton Beam Therapy for Patients With Liver Metastasis of Colorectal Cancer
  • April 5, 2022
    Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)
  • April 5, 2022
    A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors